Skip to Content

BioELife Corp LITH

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LITH is trading at a 316% premium.
Price
$0.00
Fair Value
$4.35
Uncertainty
Extreme
1-Star Price
$8.38
5-Star Price
$2.54
Economic Moat
Btbk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LITH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.51 / $1.10
Market Cap
$9.41
Volume/Avg
275 / 8,057

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

BioELife Corp is engaged in manufacturing and distribution of Cannabinoid products. The company's products portfolio includes Combo Adult Gummies with Chirorub; Combo Tincture with Chirorub; Intensive Relief Rub; Tinctures; Adult Gummies; Premium Pre-Rolls; and Flower.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
LITH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LITH
Quick Ratio
0.54
Current Ratio
0.54
Interest Coverage
−25.84
Quick Ratio
LITH

Profitability

Metric
LITH
Return on Assets (Normalized)
−333.92%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−726.35%
Return on Assets
LITH
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class APhgstntfgFfhqh$79.4 Bil
MKKGY
Merck KGaA ADRVblgfkwxvMqlmjr$79.0 Bil
HLN
Haleon PLC ADRZrtppccPqqd$38.5 Bil
VTRS
Viatris IncMgfklnnxZvsp$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYbrbbyyGdr$11.7 Bil
CTLT
Catalent IncWpyxprhqRhjymd$10.0 Bil
CURLF
Curaleaf Holdings IncVygmvsrwJqhq$4.2 Bil
PRGO
Perrigo Co PLCLgjcbzrgrRbbwr$4.1 Bil
PBH
Prestige Consumer Healthcare IncKqwkfkhqRrwyyp$3.2 Bil
GTBIF
Green Thumb Industries IncTwjpjtgtHwrrt$3.1 Bil

Sponsor Center